Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2016 Oct 15.
Published in final edited form as: J Immunol. 2015 Sep 14;195(8):3793–3802. doi: 10.4049/jimmunol.1500874

ACUTE PHASE DEATHS FROM MURINE POLYMICROBIAL SEPSIS ARE CHARACTERIZED BY INNATE IMMUNE SUPPRESSION RATHER THAN EXHAUSTION1

Evan L Chiswick 1, Juan R Mella 2, John Bernardo 3, Daniel Remick 1
PMCID: PMC4592823  NIHMSID: NIHMS714522  PMID: 26371253

Abstract

Sepsis, a leading cause of death in the U.S., has poorly understood mechanisms of mortality. To address this, our model of Cecal Ligation and Puncture (CLP) induced sepsis stratifies mice as predicted to Live (Live-P) or Die (Die-P) based on plasma IL-6. Six hours post-CLP, both Live-P and Die-P groups have equivalent peritoneal bacterial colony forming units and recruitment of phagocytes. By 24hr, however, Die-P mice have increased bacterial burden, despite increased neutrophil recruitment, suggesting Die-P phagocytes have impaired bacterial killing. Peritoneal cells were used to study multiple bactericidal processes: bacterial killing, Reactive Oxygen Species (ROS) generation, and phagocytosis. Total phagocytosis and intra-phagosomal processes were determined with triple-labeled E.coli, covalently labeled with ROS and pH sensitive probes, and an ROS/pH insensitive probe for normalization. While similar proportions of Live-P and Die-P phagocytes responded to exogenous stimuli, Die-P phagocytes showed marked deficits in all parameters measured, thus suggesting immunosuppression rather than exhaustion. This contradicts the prevailing sepsis paradigm that acute phase sepsis deaths (<5 days) result from excessive inflammation, whereas chronic phase deaths (>5 days) are characterized by insufficient inflammation and immunosuppression. These data suggest that suppression of cellular innate immunity in sepsis occurs within the first six hours.

Introduction

Sepsis is an immune mediated immune disorder costing society approximately $24 billion annually (1), and claiming over 200,000 lives per year (2). Despite causing a similar number of lives lost as cancer, there are few treatment options available. Currently, patients receive aggressive treatment that includes fluid resuscitation, vasopressors, and broad spectrum antibiotics (3). Despite these interventions, post-mortem studies revealed the majority of patients still had infectious foci present (4), thus suggesting a deficit in bacterial clearance.

Neutrophils and macrophages comprise the phagocytic arm of the innate immune system largely responsible for eradicating a bacterial infection. Following infection, tissue macrophages engage the pathogen and secrete distress factors to recruit neutrophils and inflammatory monocytes. Neutrophils help to neutralize the infection by secreting Neutrophil Extracellular Traps (NETs) (5), and/or by phagocytizing microbes and exposing them to Reactive Oxygen Species (ROS) and cationic proteases (6). Similarly, macrophages and inflammatory monocytes phagocytize microbes and process them in a manner similar to endosomal cargo, ultimately fusing with lysosomes and digesting the bacteria via pH sensitive proteases (7). As the first responders in an immune response, they are central to the initiation of sepsis.

Cecal Ligation and Puncture (CLP) induced peritonitis in outbred mice produces a spectrum of inflammation ranging from a rampant inflammatory response that is thought to become dysregulated, leading to immune paralysis, bacterial overgrowth, and death (8). At the other end of the spectrum is a tightly regulated response that clears pathogens without inducing host damage. Studies have shown that altering leukocyte recruitment (9), or enhancing leukocyte function result in decreased bacterial burden (10), increased organ perfusion (11, 12), and ultimately increased survival. However, the majority of these studies compare sham-operated animals to CLP-operated. Although this approach helps define the host response to sepsis, it may be less appropriate for delineating the mechanisms of sepsis mortality.

Previous studies have shown that within 6hr of CLP in mice, circulating biomarkers can be used to accurately predict mortality during the acute phase of sepsis (13). This powerful capability enables stratified interventions to assess efficacy (14, 15) and it provides a window of time in which to observe the detrimental divergence between survivors and non-survivors. This approach revealed that similar peritoneal bacterial CFUs and phagocyte recruitment occurs 6 hours after CLP. However by 24hr, non-survivors recruited significantly more phagocytes, yet they also showed significantly increased bacterial burden (16).

We hypothesized that phagocytes from non-survivors were impaired in their bacterial killing capacity. If the cell function was reduced, the host attempted to correct by increasing the numbers of phagocytic cells. The current study examined whether reduced cellular killing of bacteria occurs in mice predicted to die, and define the mechanisms of this impairment.

Methods

Animals

Female ICR (CD-1) mice (Harlan-Sprague Dawley, Inc., South Easton, MA) 24-28 grams were used for all studies. Mice were received and acclimated to our housing room for at least 96 hours prior to surgery, and cared for as previously described (16). The experiments were approved by the Boston University Animal Care and Use Committee.

Sepsis Model

Cecal ligation and puncture was performed as first described (17) with minor modifications (16, 18). Approximately two-thirds the length of the cecum from the distal tip was ligated, then double punctured longitudinally with 16 gauge needle. Mice were resuscitated with 1mL saline (37°C) with buprenorphine (0.05mg/kg) for pain management (1 injection every 12 hours for two days). Antibiotics (25mg/kg imipenem) were administered 2 hours post-CLP, then once every 12 hours for 5 days.

Sampling

Blood sampling was performed initially at 6 and 24 hours to generate IL-6 Receiver Operator Characteristic curves and discrimination levels for predicting survival. 20uL blood was collected by facial vein puncture and diluted 1/10 in PBS containing 3.38mM EDTA tripotassium salt. Blood was centrifuged for 5 min 1000 × g, and the plasma frozen at −20°C. For mice that were sacrificed, blood was collected from the retro-orbital venous plexus under anesthesia (Ketamine/Xylazine), followed by euthanasia via cervical dislocation. Plasma collected at 6 and/or 24 hours was analyzed for IL-6 concentrations by ELISA as previously described (19).

The peritoneal cavity was lavaged as previously described (16). Cell pellets were resuspended in 2mL wash buffer (PBS + 0.5% Bovine Serum Albumin) and 100uL retained for total cell counts and cytospins. The remaining cell volume was underlaid with 2mL 30% sucrose (w/v) in PBS and centrifuged for 8 minutes at 450 × g to remove extracellular bacteria (20). The supernatant containing bacteria was aspirated and the cell pellet was resuspended in 3mL wash buffer. 1mL of 100% isotonic Percoll in PBS was added to the cell volume to generate a 25% Percoll solution. This was underlaid with 1mL Histopaque 1.119 g/mL and then centrifuged for 25 min at 500 × g. The viable leukocytes were located at the Percoll Histopaque interface. Light debris was aspirated from the 25% Percoll layer, dead cells were removed from the pellet by pipette (21), and the remaining viable cells were washed once, followed by resuspension in HBSS containing Ca2+ and Mg2+ + 1% BSA. Cells were enumerated with a Beckman-Coulter particle counter model ZF (Coulter electronics Inc., Hialeah, Fl).

Peritoneal Bacterial Quantification

100uL of the 1st mL of lavage fluid was serially diluted with HBSS and cultured on 5% sheep blood agar plates (Fisher Scientific) for 24 hours at 37°C in anaerobic or aerobic conditions, followed by CFU enumeration.

Bacterial Killing by Peritoneal Cells

Streptomycin resistant Escherichia coli (E. coli strain HB101) were grown to log-phase in Tryptic Soy Broth containing streptomycin. Bacteria were opsonized 20 minutes at 37°C with normal mouse plasma, added to peritoneal cells (4×106/ml) at a 5:1 microbe:cell, then incubated for 1 hour at 37°C. Killing was stopped by lysis with H2O pH 11 (22). Serial dilutions were cultured overnight on streptomycin-infused Tryptic Soy Agar plates to prevent contamination. The % bacteria killed = (CFU sample + bacteria) / (bacteria alone).

Neutrophil and Macrophage ROS Burst

ROS was measured by the conversion of non-fluorescent Dihydrorhodamine 1,2,3 (DHR-123) to fluorescent R-123. Cells (4×106/ml) were loaded with 2uM DHR-123 and stimulated with opsonized heat-killed E.coli (20:1 bacteria:cell) or 100nM Phorbol-12 Myristate-12 Acetate (PMA) for 30 minutes at 37°C, then chilled on ice, followed by extracellular marker staining for flow cytometry. The ROS burst was calculated by the % increase of R-123 (gMFI) of stimulated cells over unstimulated cells. Cellular Fc-Receptors were blocked with Fc Block (BD Biosciences). Cell viability was determined with Sytox Blue stain (Life Technologies), added 5min before acquisition. The following antibodies were used: CD11b (clone M170), CD19 (1d3), CD3e (145-2C11), Ly6G (1A8), Gr-1 (RB6-8C5), F480 (Ci-A13), Ly6C (HK1.4). Only Sytox Blue negative events (Live Cells) were used for gating. Doublet discrimination was performed by Fsc-A vs Fsc-H.

Basal ROS and ROS Burst Kinetics

Peritoneal cells were added to white-opaque microplate wells in duplicate at a concentration of 4×106/mL. Luminol was present at 20uM. Cells were placed in a temperature controlled fluorescent plate reader (Tecan Infinite m1000) and warmed to 37°C for 5 minutes. Stimulus was then added (100nM PMA or 20:1 bacteria:cell) and chemiluminescence was measured every ~10s (0.5s integration time) followed by mechanical shaking.

3X-Labeled Bacteria Preparation

Labeling was performed as previously published (23). Briefly 2×1010/mL of heat-killed (80°C 1hr) HB101 E.coli were sequentially labeled with 500uM DCF-SE to detect ROS, 50uM pHrodo-SE to detect pH changes, and 159uM Alexafluor-350-SE to calibrate DCF/pHrodo fluorescence (Life Technologies). Labeling was performed in PBS pH 9.0, degassed and purged with N2 to minimize auto oxidation of DCF. ~1.5×1010/mL bacteria were opsonized with 1/10th volume of normal mouse plasma (heparinized) and anti-E.coli antibodies (50ug/mL) (Life Technologies). The use of particles covalently labeled with multiple fluorescent indicators/substrates provides temporal, spatial, and calibrated information for phagocytosis and phagosomal events that are not readily available with most cell permeable dyes. These approaches have been validated in previous publications (24, 25).

Phagocytosis and Phagosomal ROS/Acidification of 3X-Labeled Bacteria

Peritoneal cells were loaded into polypropylene cryovials at 4×106/mL. While on ice, ~150 bacteria/cell were added to cells. Tubes were transferred to a water bath at 37°C, placed on a stir plate, and agitated at lowest speed for 30 minutes with 7×2mm micro stir bars. For controls, samples were also incubated on ice for 30 minutes. Following incubation, cells were kept on ice until data acquisition with an LSRII flow cytometer (BD Biosciences).

Ice controls were acquired first. ~30,000 events were collected to measure attachment. Then, Trypan Blue (TB) was added to quench extracellular fluorescence (0.25% final concentration), incubated on ice for 1 minute, and then ~30,000 gated events were collected. Cells that were allowed to phagocytize were only acquired with TB present. Non-debris cells were gated on by Fsc/Ssc. Doublets were removed by Fsc-h vs. Fsc-w. Phagocytosis+ gates were constructed for each sample based off its own ice control (no phagocytosis occurs).

DCF, pHrodo, and Alexafluor-350 fluorescence was excited by 488, 561, and 355nm lasers, respectively, and their emission was collected by (wavelength/band pass) 530/15, 590/10, and 450/50 filters, respectively. It was important to use a custom 590/10 filter for pHrodo because Trypan Blue auto fluoresces when bound to protein and its emission begins at ~615nm. Data were analyzed with Flowjo (Treestar Inc.). Derived parameters (i.e. calibrated fluorescence) were constructed so that DCF or pHrodo fluorescence for each event was divided by the fluorescence of Alexa-350 for that event. The ROS index was calculated by dividing the DCF/Alexa ratio of the cell by the DCF/Alexa ratio of the bacteria. Similar calculations were performed for the Acidification Index.

Statistical Analysis

Statistics were performed using Prism 5 software (Graphpad Software, San Diego, CA). For comparison between 2 groups, an unpaired Student t test was used. For survival analysis, a Kaplan-Meier curve and log rank survival was performed with a 95% confidence interval. All values were expressed in mean ± SE.

Results

Characterization of CLP-Induced Sepsis: Similar Beginning, Dissimilar Fate

To study the mechanisms of mortality, our lab uses a murine model of peritoneal sepsis induced by cecal ligation and puncture (CLP). This model, which includes fluid resuscitation and antibiotic treatment, produces approximately 50% mortality within the first five days of sepsis (Acute phase). Mice were subjected to CLP, a small sample of blood was collected at 6 and 24 hours post-CLP, and the mice were followed for survival. Monitoring plasma IL-6 levels of survivors/non-survivors shows that mice that succumb to sepsis have significantly elevated IL-6 24hr post CLP (Figure 1A) as well as at 6hr post-CLP (data not shown). Receiver Operator Characteristic curves were used to generate IL-6 discrimination values to stratify mice as predicted to live (Live-P) or predicted to die (Die-P), as described previously (13). This discrimination value accurately predicted survival (Fig. 1B). Using the discrimination value, mice were sacrificed in subsequent experiments at 6hr or 24hr post-CLP and posthumously stratified into Die-P and Live-P.

Figure 1.

Figure 1

Phagocyte Dysfunction Precedes Death from CLP-induced Sepsis. CLP was performed to induce ~50% mortality in ICR CD1-outbred mice. Plasma was collected at 24 hours post CLP and animals were monitored for survival. The mice who died in the first 5 days had significantly higher plasma levels of IL-6 (A). ROC curve analysis was used to generate IL-6 values predictive for mortality. None of the mice with IL-6 >3.13 ng/ml survived (B). Peritoneal bacterial loads and cellular recruitment between Live-predicted/Die-predicted mice were compared following euthanasia at 6 or 24 hours post-CLP. Panel C total peritoneal cells, Panel D bacterial CFUs. *=p<0.05, ***= p<0.0001 between the indicated groups.

As reported previously by this lab, Die-P mice have similar numbers of cells in their peritoneum as compared to Live-P mice at 6hr Post-CLP (Fig. 1C). Similarly, there is no difference in the number of bacteria within the peritoneal cavity at 6hr post-CLP (Fig. 1D) (16). This demonstrates that our CLP model is consistent, but more importantly, that both Live-P and Die-P groups were subjected to a similar initial bacterial insult with a similar initial cellular response. Despite a nearly identical 6hr response, by 24hr post-CLP Die-P mice have increased peritoneal cells (Fig. 1C) and bacteria (Fig. 1D). The divergence from similar phagocyte recruitment and bacterial burden at 6hr post-CLP, to increased phagocytes and bacterial numbers at 24hr post-CLP suggests an early defect in phagocyte function in Die-P mice.

Die-P Phagocytes Show Impaired Bactericidal Activity

To test the idea that impaired phagocyte function was responsible for the increased bacterial burden observed in Die-P mice, peritoneal cells were carefully processed to remove excess bacteria and dead cells, and the cells were then used in a bacterial killing assay. This assay assessed the ability of the peritoneal cells to kill exogenous E. coli. Interestingly, at 6hr post-CLP when cellular recruitment and bacterial burden were similar, differences in cellular function were already present. When bacterial killing was examined using live E.coli, Die-P mice showed a marked reduction in bacteria killed compared to Live-P mice within 6hr post-CLP and this persisted through 24hr (Fig. 2). Previous studies have shown that increased bacterial burden correlates with mortality (26-28) and that source control (removal of infectious foci) increases survival (13). In conjunction with those studies, the current data strongly suggest that the reduced bacterial killing within the first 6 hours of sepsis leads to subsequent mortality.

Figure 2.

Figure 2

Die-P Mice Exhibit Impaired Bacterial Killing of E. coli at 6 and 24hr post-CLP. E.coli were incubated with or without peritoneal cells for 1hr and then plated overnight for CFU counts. Data from at least 3 independent experiments. N=7-13/group at 6hr, 7-8/group at 24hr, where N represents an individual mouse. ***= p<0.0001 comparing the indicated groups.

Mechanisms of reduced bacterial killing

To determine why Die-P peritoneal phagocytes kill fewer bacteria than Live-P, bactericidal mechanisms were further examined. While multiple mechanisms are important in the clearance of pathogens, ROS generation is integral to the microbial killing process, as evidenced by humans with Chronic Granulomatous Disease (CGD), a condition where patients are prone to recurrent bacterial infections due to a mutation that renders the ROS producing NADPH Oxidase (NOX) complex inoperable. To assess the ROS burst, peritoneal cells were loaded with DHR-1,2,3, stimulated with opsonized pHrodo-labeled E.coli (OpH-E.coli) or PMA, and analyzed by flow cytometry.

Phagocytes consist primarily of neutrophils and macrophages. To determine if impairments in either cell type were responsible for the decreased bacterial killing, both neutrophil and macrophage function were distinguished through the use of cell specific markers. Neutrophils were defined as CD11b+, LY6G Hi and monocytes/macrophages were defined as CD11b+, LY6G lo/neg (Supplemental Fig. 1) (29, 30). Though the analyzed macrophage population expressed the classical macrophage marker F4\80, its variable level of expression in Die-P mice made it unsuitable for gating purposes (Supplemental Fig. 1G). Recent work has also shown that eosinophils express F4\80, and inflammatory conditions induced by thioglyocollate result in decreased F4\80 expression by macrophages (31). This is likely due in part to newly recruited monocytes/macrophages that express little F4\80 (32).

Distinguishing bactericidal activity between neutrophils and macrophages showed that both populations likely contributed to the impaired bacterial killing observed in Die-P peritoneal cells. Following incubation with OpH-E.coli, there is a marked increase in ROS production measured by R-1,2,3 fluorescence in Live-P neutrophils, whereas the histograms for stimulated/unstimulated Die-P neutrophils are virtually superimposable (Fig. 3A). Die-P neutrophils produce significantly less ROS than their Live-P counterparts in response to OpH-E.coli within 6hr after induction of sepsis (Fig. 3B-left panel), and this deficiency persists through 24hr post-CLP. The use of OpH-E.coli as a stimulus is physiologically relevant; it measures how a cell would likely respond in vivo when encountering cecal bacteria. This process leads to ROS production subsequent to cell surface receptor ligation and signaling. However, if there were decreased receptor expression, desensitization, or other means of blunted receptor signaling, the ROS burst may fail to occur despite the ROS machinery (e.g. NOX) remaining fully functional. To determine if the differences in ROS production were due to impaired Pattern Recognition Receptor (PRR) signaling, or a decreased capacity to generate ROS, PMA was used to stimulate the cells. PMA, as a non-specific activator of ROS production, bypasses the requirement of PRR signaling for NOX activation. Following PMA stimulation, Die-P neutrophils were shown to be capable of generating ROS, albeit significantly less so than Live-P at both time points (Fig. 3B-right panel). Similar differences in ROS production in response to either stimuli were also evident in macrophages (Fig. 3C).

Figure 3.

Figure 3

Die-P Peritoneal Phagocytes have Decreased ROS Burst. (A) Live-P and Die-P peritoneal cells loaded with Dihydrorhodamine-1,2,3 were incubated with OpH-E.coli or PMA to delineate physiological-response ROS or Cellular ROS Capacity via flow cytometry. Histograms show representative staining of PMN incubated with (red histogram) or without OpH-E.coli (blue). (B-C) Bar graphs show results from 3 independent experiments (N=4-7 mice per group. (D-E) Representative ROS Kinetics for unstimulated (basal) (D) or Opsonized-E.coli (E) stimulated cells for Live-P and Die-P mice, as measured by Luminol based chemiluminescence (RLU). (F) Bar graphs show the Area Under the Curve (AUC) calculated for samples in unstimulated and stimulated conditions. (N=3 mice / group). (D). *=p<0.05, **=p<0.01,***=p<0.001 between live-P and die-P. Black bars = Die-P mice, Open bars = Live-P mice.

Diminished ROS generation alone does not explain decreased bacterial killing, as macrophages with defective NOX and inducible nitric oxide synthase (iNOS) enzymes are as bactericidal as their NOX/iNOS competent counterparts (33). This occurs because, following internalization, the phagosome acidifies and enables pH-sensitive antimicrobial products to destroy the phagosome’s microbial cargo. Since pHrodo is a pH sensitive fluorophore, the term “pHrodocytosis” was used to reflect the fact that differences in fluorescence could be due to differences in the number of attached and/or internalized bacteria, or due to differences in pH. Comparing pHrodo (OpH-E.coli) fluorescence showed decreased “pHrodocytosis” for neutrophils and macrophages at both time points (data not shown).

Interestingly, Die-P phagocytes produce less ROS in response to OpH-E.coli stimulation compared to the unstimulated state (Fig. 3A-right histogram, B,C-black bars). It is important to note that “unstimulated control” cells are not naïve cells; they were harvested from the peritoneums of mice with extreme peritonitis. Although these cells are already stimulated, there were significantly different responses at 6hr post-CLP, a time at which bacterial loads (i.e. pre-assay stimulation) were similar (Fig 1D). A caveat to end-point measurements for ROS lies in that our analysis, and many others’, (34-37), employ normalization to an unstimulated control that is producing basal ROS. Since these cells were procured from inflamed tissue, it may be that Die-P phagocytes appear to generate less ROS than Live-P phagocytes in response to stimuli because the Die-P cells are already generating maximal ROS (i.e. hyperstimulated). If the Die-P mice were hyperstimulated it would be difficult to detect any increase in ROS upon further stimulation. To determine if Die-P cells were hyperstimulated, a chemiluminescence based kinetic assay was used to measure ROS. Basal ROS data show that Die-P peritoneal cells produce less ROS prior to stimulation, thus arguing against the hyperstimulation hypothesis (Fig. 3D). Similar to what was observed with the flow cytometric ROS measurements, opsonized-E.coli (Fig. 3E) resulted in less ROS production in Die-P cells. The sum of the cellular response to either opsonized-E.coli or PMA was calculated as the total area under the curve (Fig. 3E, F). Importantly, luminol chemiluminescence shows that Die-P cells do generate more ROS from opsonized-E.coli as compared to basal conditions, unlike what was observed by flow cytometry (Fig. 3B-C, leftmost panels). It was determined that the increased fluorescence seen in Die-P cells prior to exogenous stimulation (Fig. 3A) was due to increased autofluorescence (data not shown). Importantly, luminol chemiluminescence is not confounded by cellular autofluorescence. Furthermore, whereas opsonized-E.coli incubation produces a minuscule ROS burst in Die-P cells, PMA stimulation results in a marked increase in ROS production (Fig. 3F). This suggests that although Die-P cells retain the capacity to respond more vigorously to bacteria with ROS, they fail to do so. Taken together, these data suggest that Die-P cells are not hyperstimulated, but may instead be exhausted or suppressed, resulting in decreased bacterial killing (Fig. 2), increased bacterial burden, and increased mortality (Fig.1).

Die-P Phagocytes are Immunosuppressed

The preceding data suggest that Die-P phagocytes are impaired compared to Live-P, but the data do not indicate the mechanism. Die-P cells may exhibit impaired bactericidal activity because fewer cells have the capacity to respond to stimuli (i.e. exhausted cells). Alternatively, a similar fraction of stimuli-responsive cells may exist between groups, but the Die-P response is significantly weaker than Live-P (i.e. suppressed cells).

To address this, a saturating dose of labeled bacteria was used to stimulate the peritoneal phagocytes. A saturating dose is defined as the number of bacteria per cell needed to stimulate the maximum number of cells to phagocytize the bacteria. This presumably occurs due to ligation of all available receptors, as suggested by a study in human PMNs which showed that despite equal binding of ligand by all cells, only a subset of cells will actually respond (i.e. phagocytize) (38). In conjunction with Trypan blue to quench extracellular fluorescence, cells that have internalized bacteria can be discriminated from those that have not by comparing cells incubated with bacteria on ice versus 37°C (Fig. 4A).

Figure 4.

Figure 4

Die-P Phagocytes Are Suppressed in Phagocytosis. 3X-Labeled E.coli were incubated with peritoneal cells for 30min. Gating for Phagocytosis+ events: (A) Ice control left, 37°C incubation right. Trypan blue was used to quench extracellular fluorescence. The percentage of Peritoneal cells from Live-P and Die-P mice that phagocytize bacteria at 6hr (B) and 24hr post-CLP (C), and the overall amount of bacteria internalized at 6hr (D) and 24hr (E). Data collected from 3-4 independent experiments. N=4/group for 6hr, N=5-7/group for 24hr. *p<0.05, ***p<0.0001 Live-P vs Die-P.

Using a saturating dose, similar proportions of cells phagocytized the bacteria at both 6hr (Fig. 4B) and 24hrs (Fig. 4C). However, Die-P cells phagocytized significantly less bacteria overall than Live-P at both the early and later time points (Fig. 4D,E). Decreased phagocytosis could be due to decreased attachment of the bacteria to the cell surface. However, this does not seem likely as both groups exhibit similar levels of bacterial fluorescence when incubated on ice and without addition of TB quenching agent (Data not shown). These data support the differences observed in bacterial killing, and suggest that Die-P peritoneal cells are suppressed in their function, but are not exhausted since a similar percentage of cells do phagocytize, albeit significantly less than seen in Live-P.

Quantifying phagosomal responses

Intraphagosomal processes were examined to further define the mechanism of suppression and ascertain whether bacteria were still exposed to the caustic microbicidal environment following internalization. This was accomplished with a recently developed technique in which E. coli were triple labeled with Dichlorofluorescein (ROS sensor), pHrodo (phagolysosome fusion, i.e. acidification), and Alexafluor-350 (ROS/pH insensitive). A specific gating strategy was used to determine the relative oxidation and/or acidification of the phagosomes. For all phagocytizing cells (Fig. 5A), DCF/pHrodo fluorescence (Fig. 5B) was normalized to Alexafluor-350 fluorescence. In this manner, DCF/pHrodo fluorescence can be attributed to the amount of oxidation/acidification, and not to differences in the amount of labeled bacteria within the cell. This approach identified two distinct populations of High and Low ROS cells (Fig. 5C). Furthermore, cell sorting of high ROS and low ROS cells revealed the cells to be PMNs or macrophages, respectively (Fig. 5D). This agrees with previous literature that showed the proclivity of PMNs to produce increased ROS (39), while macrophages have more phagosomal acidification (40) and an increased capacity for phagocytosis (41).

Figure 5.

Figure 5

Gating for Neutrophils and Macrophages based on Phagocytic Activity. 3X-Labeled E.coli were incubated with peritoneal cells for 30min and Trypan blue added to quench extracellular fluorescence. (A) Contour Plots for Phagocytosis+ events. (B) DCF and pHrodo fluorescence of phagocytosis+ events, (C) Normalization of DCF and pHrodo fluorescence to Alexa-350 fluorescence. (D) Cytospin preparations of sorted high ROS and low ROS events reveals them to be neutrophils and macrophages, respectively (D). (E) The overall amount of internalized bacteria for neutrophils and macrophages was calculated via its Alexa-350 fluorescence (E). *p<0.05,**p<0.01 ***p<0.001, Live-P vs Die-P. N=4 at 6hr and 5-7 at 24hr from 3 independent experiments.

To determine if the decreased phagocytosis of Die-P cells was due to decreased phagocytosis by either macrophages or neutrophils, the peritoneal phagocytosis data (Fig. 4D,E) were re-examined by first stratifying the cell populations based on High or Low phagosomal ROS production (Fig. 5C). This approach showed that both Die-P neutrophils and macrophages are suppressed in their ability to phagocytize within 6hr post-CLP, and this continues through 24hr (Fig. 5E), thus suggesting why Die-P cells kill fewer bacteria than Live-P.

Similar to their impaired ability to phagocytize (Figs. 4,5), Die-P peritoneal phagocytes also show decreased phagosomal maturation (i.e. ROS/acidification) as compared to Live-P.

Differences in ROS production and phagosome acidification

Although significant differences in PMN phagocytosis between Live-P and Die-P existed by 6hr (Fig 5E), there were not significant differences in the generation of phagosomal ROS, the hallmark of PMN bacterial killing (Fig. 6A). However, by 24hr there were significant differences in phagosomal ROS (Fig. 6B), with Live-P demonstrating an increased burst as compared to 6hr, whereas Die-P PMNs did not show this improvement. Although less pronounced in PMNs, phagosomal acidification and fusion with lysosomes contributes significantly to bacterial killing (42). Similar to PMN ROS, no significant differences in PMN phagosomal acidification existed within 6hr post-CLP (Fig. 6C), but significant differences did emerge by 24hr (Fig. 6D). In contrast to Die-P PMNs, macrophage phagosomal acidification was significantly decreased within 6hr post-CLP (Fig. 6E) and this continued through 24hr (Fig. 6F).

Figure 6.

Figure 6

Die-P Peritoneal Phagocytes are Suppressed in Phagosomal Maturation. 3X-Labeled E.coli were incubated with peritoneal cells for 30min and Trypan blue added to quench extracellular fluorescence. PMN phagosomal ROS was calculated by calibrating DCF (ROS sensitive) fluorescence to Alexa-350 fluorescence (ROS/pH insensitive) at 6hr (A) and 24hr post-CLP (B). PMN phagosomal acidification was calculated by normalizing pHrodo fluorescence to Alexa-350 at 6hr (C) and 24hr (D). Macrophage phagosome acidification at 6hr (E) and 24hr (F). *p<0.05,**p<0.01 ***p<0.001 Live-P vs Die-P. N=5-7 from 3 independent experiments.

Taken together, these data strongly support that Die-P phagocytes are suppressed in their ability to internalize bacteria, and to create the caustic conditions necessary to kill internalized bacteria. This suppression was evident within 6 hours after the onset of sepsis. This in turn explains why despite increased phagocyte recruitment, Die-P mice fail to eliminate their infection and subsequently die.

Discussion

The most important finding in this study is that despite receiving equivalent inoculums and recruiting similar numbers of phagocytes in response to the inoculum, Die-P peritoneal phagocytes are impaired in their ability to kill bacteria. These cellular defects were present in the very first hours of sepsis and became progressively worse. Less obvious but of equal concern is that without proper stratification of mice according to their likelihood of survival (i.e. mild vs severe sepsis), considerable variability may confound studies that compare sham operated mice to septic mice. For example, our lab has published that cell function, renal function, bacteria, and cytokines differ significantly between survivors and non-survivors (13, 43). Our lab has also published that high IL-6 levels merely correlate with, but do not mediate mortality from CLP (44). These studies suggest that stratification would be of considerable benefit in human studies where heterogeneity in individuals and their responses are more pronounced. In further support of stratification and our findings of decreased bacterial killing preceding death, Danikas et al. showed phagocytic activity as prognostic for outcome in human sepsis (45).

While numerous studies have argued for and against organ injury preceding death from sepsis (43, 46, 47), this study strongly suggests that early phagocytic impairment (within 6hr) ultimately leads to uncontrolled microbial growth and death. This occurs even with the use of effective broad spectrum antibiotics. It may be that failure to contain the initial infection allows the intense inflammatory reaction to ripple throughout the organism, leading to organ injury. The successful eradication of microbial pathogens requires recruitment of myeloid cells to the site of infection (48, 49). To that end, other labs have shown that increasing or inhibiting neutrophil recruitment following CLP (50, 51) affects bacterial burden and animal survival. Our lab has shown that augmented recruitment of neutrophils also increases survival (16). However, that study and this one demonstrate that the mice that are predicted to die do not fail to recruit neutrophils or monocytes/macrophages as compared to the mice predicted to live. In fact, Die-P mice recruit more cells by 24hr post-CLP. Similar findings were recently reported that used CLP to produce ~ 60% mortality in control mice (52) and demonstrated that without GM-CSF producing B-cells, CLP resulted in 100% mortality. Most importantly, as it relates to this study, the B-cell GM-CSF−/− mice recruited significantly more neutrophils to the peritoneum, yet still had increased bacterial burden, increased inflammatory mediators, and decreased phagocytosis, as observed in our model. Taken all together, this suggests that while phagocyte recruitment is important, their functional status is more important.

Although this study strongly argues for impaired phagocyte function as contributing to death, it does not address the role of lymphocytes, which are fundamental to an immune response. Others have shown that treatments affecting lymphocyte apoptosis and function result in increased survival (53, 54). While these studies did not stratify by survival likelihood, it is interesting to speculate that impaired lymphocyte function or death drives the phagocyte dysfunction observed in our model. Certainly, the report by Rauch et al. detailing GM-CSF producing B-cells supports this. Also not addressed is the role endotoxin tolerance (ET) may have in phagocytic suppression. The ET phenotype of monocytes/macrophages is one of epigenetic remodeling (55) and decreased cytokine production with increased phagocytosis (56). It is plausible that Live-P phagocytes experience similar rewiring that promotes bacterial clearance along with decreased cytokine production (i.e. IL-6).

Another limitation to this study is that only peritoneal cells were evaluated for performance. It would be interesting to know if Die-P phagocytes become impaired upon their arrival to the peritoneum, or if their impairment exists prior to their arrival. Myeloid Derived Suppressor Cells (MDSCs) may play a role if the phagocytes are suppressed prior to recruitment to the site of infection. Delano et al. showed that CLP results in suppressed ROS burst by monocytic splenocytes and bone marrow neutrophils, suggesting that phagocytic suppression is systemic. It will be important to determine to what extent systemic alterations are implicated in a survivor/non-survivor model of sepsis. MDSCs have been shown to improve or hinder survival from CLP, depending on the maturity of the MDSCs (57, 58). Unfortunately the phenotypic markers for MDSCs (e.g.Cd11b+,Gr-1+) are insufficiently specific to readily distinguish them from the peritoneal neutrophils or macrophages/monocytes in this study.

There is considerable evidence that suggests that overstimulation of cells with contradictory stimuli (e.g. pro and anti-apoptosis agents) can result in a terminally non-responsive state, affectionately termed “zombie cells” (59). Along similar lines, Die-P mice demonstrate a significantly larger surge in pro and anti-inflammatory mediators in their peritoneum and plasma (16), potentially creating the conditions for terminally non-responsive cells that render them incapable of defending the host. In light of this, perhaps the most hopeful finding of this study is that Die-P cells are functionally intact and equally capable of responding to bacteria, although they are deficient in both the amount they can phagocytize and how they process their phagosomal cargo. Since they are responsive, phagocytes would be attractive targets for functional modulators, such as antagonists of adenosine receptors or programmed death receptor-1, both of which have been suggested to increase phagocyte function and improve survival from sepsis (15, 60).

Supplementary Material

1

Acknowledgements

We thank Elizabeth R. Simons for her generous intellectual and technical support. We also thank the Boston University Medical Center Flow Cytometry Core Facility for their support.

Footnotes

1

This work was partially supported by NIH grants 5T32AI007309 and T32 HL 007501, as well as NIH grant R01 GM97320.

Authorship

Contribution: E.L. Chiswick performed experiments and analyzed data. J.R. Mella cultured bacteria from peritoneal cavity and prepared data. J. Bernardo provided equipment, reagents, technical expertise, and intellectual support. E.L. Chiswick and D.G. Remick conceived the study and wrote the manuscript.

References

  • 1.Lagu T, Rothberg MB, Shieh MS, Pekow PS, Steingrub JS, Lindenauer PK. Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007. Critical care medicine. 2012;40:754–761. doi: 10.1097/CCM.0b013e318232db65. [DOI] [PubMed] [Google Scholar]
  • 2.Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. The New England journal of medicine. 2003;348:1546–1554. doi: 10.1056/NEJMoa022139. [DOI] [PubMed] [Google Scholar]
  • 3.Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb SA, Beale RJ, Vincent JL, Moreno R. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41:580–637. doi: 10.1097/CCM.0b013e31827e83af. [DOI] [PubMed] [Google Scholar]
  • 4.Torgersen C, Moser P, Luckner G, Mayr V, Jochberger S, Hasibeder WR, Dunser MW. Macroscopic postmortem findings in 235 surgical intensive care patients with sepsis. Anesthesia and analgesia. 2009;108:1841–1847. doi: 10.1213/ane.0b013e318195e11d. [DOI] [PubMed] [Google Scholar]
  • 5.Urban CF, Ermert D, Schmid M, Abu-Abed U, Goosmann C, Nacken W, Brinkmann V, Jungblut PR, Zychlinsky A. Neutrophil extracellular traps contain calprotectin, a cytosolic protein complex involved in host defense against Candida albicans. PLoS pathogens. 2009;5:e1000639. doi: 10.1371/journal.ppat.1000639. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Segal BH, Grimm MJ, Khan AN, Han W, Blackwell TS. Regulation of innate immunity by NADPH oxidase. Free radical biology & medicine. 2012;53:72–80. doi: 10.1016/j.freeradbiomed.2012.04.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Vieira OV, Botelho RJ, Grinstein S. Phagosome maturation: aging gracefully. The Biochemical journal. 2002;366:689–704. doi: 10.1042/BJ20020691. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Xiao H, Siddiqui J, Remick DG. Mechanisms of mortality in early and late sepsis. Infection and immunity. 2006;74:5227–5235. doi: 10.1128/IAI.01220-05. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Ocuin LM, Bamboat ZM, Balachandran VP, Cavnar MJ, Obaid H, Plitas G, DeMatteo RP. Neutrophil IL-10 suppresses peritoneal inflammatory monocytes during polymicrobial sepsis. Journal of leukocyte biology. 2011;89:423–432. doi: 10.1189/jlb.0810479. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Huang X, Venet F, Wang YL, Lepape A, Yuan Z, Chen Y, Swan R, Kherouf H, Monneret G, Chung CS, Ayala A. PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis. Proceedings of the National Academy of Sciences of the United States of America. 2009;106:6303–6308. doi: 10.1073/pnas.0809422106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Oliveira RP, Velasco I, Soriano FG, Friedman G. Clinical review: Hypertonic saline resuscitation in sepsis. Crit Care. 2002;6:418–423. doi: 10.1186/cc1541. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Theobaldo MC, Llimona F, Petroni RC, Rios EC, Velasco IT, Soriano FG. Hypertonic saline solution drives neutrophil from bystander organ to infectious site in polymicrobial sepsis: a cecal ligation and puncture model. PloS one. 2013;8:e74369. doi: 10.1371/journal.pone.0074369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Remick DG, Bolgos GR, Siddiqui J, Shin J, Nemzek JA. Six at six: interleukin-6 measured 6 h after the initiation of sepsis predicts mortality over 3 days. Shock. 2002;17:463–467. doi: 10.1097/00024382-200206000-00004. [DOI] [PubMed] [Google Scholar]
  • 14.Osuchowski MF, Connett J, Welch K, Granger J, Remick DG. Stratification is the key: inflammatory biomarkers accurately direct immunomodulatory therapy in experimental sepsis. Critical care medicine. 2009;37:1567–1573. doi: 10.1097/CCM.0b013e31819df06b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Belikoff BG, Hatfield S, Georgiev P, Ohta A, Lukashev D, Buras JA, Remick DG, Sitkovsky M. A2B adenosine receptor blockade enhances macrophage-mediated bacterial phagocytosis and improves polymicrobial sepsis survival in mice. Journal of Immunology. 2011;186:2444–2453. doi: 10.4049/jimmunol.1001567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Craciun FL, Schuller ER, Remick DG. Early enhanced local neutrophil recruitment in peritonitis-induced sepsis improves bacterial clearance and survival. Journal of Immunology. 2010;185:6930–6938. doi: 10.4049/jimmunol.1002300. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Wichterman KA, Baue AE, Chaudry IH. Sepsis and septic shock--a review of laboratory models and a proposal. J Surg Res. 1980;29:189–201. doi: 10.1016/0022-4804(80)90037-2. [DOI] [PubMed] [Google Scholar]
  • 18.Ebong SJ, Call DR, Bolgos G, Newcomb DE, Granger JI, O’Reilly M, Remick DG. Immunopathologic responses to non-lethal sepsis. Shock. 1999;12:118–126. doi: 10.1097/00024382-199908000-00005. [DOI] [PubMed] [Google Scholar]
  • 19.Nemzek JA, Siddiqui J, Remick DG. Development and optimization of cytokine ELISAs using commercial antibody pairs. J Immunol Methods. 2001;255:149–157. doi: 10.1016/s0022-1759(01)00419-7. [DOI] [PubMed] [Google Scholar]
  • 20.Campbell PA, Canono BP, Drevets DA. Measurement of bacterial ingestion and killing by macrophages. Current protocols in immunology / edited by John E. Coligan … [et al.] 2001 doi: 10.1002/0471142735.im1406s12. Chapter 14: Unit 14.16. [DOI] [PubMed] [Google Scholar]
  • 21.Zhou C, Wu J, Borillo J, Torres L, McMahon J, Lou YH. Potential roles of a special CD8 alpha alpha+ cell population and CC chemokine thymus-expressed chemokine in ovulation related inflammation. J Immunol. 2009;182:596–603. [PMC free article] [PubMed] [Google Scholar]
  • 22.Decleva E, Menegazzi R, Busetto S, Patriarca P, Dri P. Common methodology is inadequate for studies on the microbicidal activity of neutrophils. Journal of leukocyte biology. 2006;79:87–94. doi: 10.1189/jlb.0605338. [DOI] [PubMed] [Google Scholar]
  • 23.Simons ER. Measurement of phagocytosis and of the phagosomal environment in polymorphonuclear phagocytes by flow cytometry. Current protocols in cytometry / editorial board, J. Paul Robinson, managing editor … [et al.] 2010 doi: 10.1002/0471142956.cy0931s51. Chapter 9: Unit9 31. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Yates RM, Russell DG. Phagosome maturation proceeds independently of stimulation of toll-like receptors 2 and 4. Immunity. 2005;23:409–417. doi: 10.1016/j.immuni.2005.09.007. [DOI] [PubMed] [Google Scholar]
  • 25.Bernardo J, Long HJ, Simons ER. Initial cytoplasmic and phagosomal consequences of human neutrophil exposure to Staphylococcus epidermidis. Cytometry. Part A : the journal of the International Society for Analytical Cytology. 2010;77:243–252. doi: 10.1002/cyto.a.20827. [DOI] [PubMed] [Google Scholar]
  • 26.Csoka B, Nemeth ZH, Mukhopadhyay P, Spolarics Z, Rajesh M, Federici S, Deitch EA, Batkai S, Pacher P, Hasko G. CB2 cannabinoid receptors contribute to bacterial invasion and mortality in polymicrobial sepsis. PloS one. 2009;4:e6409. doi: 10.1371/journal.pone.0006409. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Hotchkiss RS, Chang KC, Swanson PE, Tinsley KW, Hui JJ, Klender P, Xanthoudakis S, Roy S, Black C, Grimm E, Aspiotis R, Han Y, Nicholson DW, Karl IE. Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte. Nat Immunol. 2000;1:496–501. doi: 10.1038/82741. [DOI] [PubMed] [Google Scholar]
  • 28.Walker WE, Bozzi AT, Goldstein DR. IRF3 contributes to sepsis pathogenesis in the mouse cecal ligation and puncture model. J Leukoc Biol. 92:1261–1268. doi: 10.1189/jlb.0312138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Rose S, Misharin A, Perlman H. A novel Ly6C/Ly6G-based strategy to analyze the mouse splenic myeloid compartment. Cytometry. Part A : the journal of the International Society for Analytical Cytology. 2012;81:343–350. doi: 10.1002/cyto.a.22012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Narni-Mancinelli E, Soudja SM, Crozat K, Dalod M, Gounon P, Geissmann F, Lauvau G. Inflammatory monocytes and neutrophils are licensed to kill during memory responses in vivo. PLoS pathogens. 2011;7:e1002457. doi: 10.1371/journal.ppat.1002457. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Misharin AV, Saber R, Perlman H. Eosinophil contamination of thioglycollate-elicited peritoneal macrophage cultures skews the functional readouts of in vitro assays. Journal of leukocyte biology. 2012;92:325–331. doi: 10.1189/jlb.1111560. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Ghosn EE, Cassado AA, Govoni GR, Fukuhara T, Yang Y, Monack DM, Bortoluci KR, Almeida SR, Herzenberg LA. Two physically, functionally, and developmentally distinct peritoneal macrophage subsets. Proceedings of the National Academy of Sciences of the United States of America. 2010;107:2568–2573. doi: 10.1073/pnas.0915000107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Fairbairn IP, Stober CB, Kumararatne DS, Lammas DA. ATP-mediated killing of intracellular mycobacteria by macrophages is a P2X(7)-dependent process inducing bacterial death by phagosome-lysosome fusion. Journal of Immunology. 2001;167:3300–3307. doi: 10.4049/jimmunol.167.6.3300. [DOI] [PubMed] [Google Scholar]
  • 34.O’Gorman MR, Corrochano V. Rapid whole-blood flow cytometry assay for diagnosis of chronic granulomatous disease. Clinical and diagnostic laboratory immunology. 1995;2:227–232. doi: 10.1128/cdli.2.2.227-232.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Elloumi HZ, Holland SM. Diagnostic assays for chronic granulomatous disease and other neutrophil disorders. Methods in Molecular Biology. 2014;1124:517–535. doi: 10.1007/978-1-62703-845-4_31. [DOI] [PubMed] [Google Scholar]
  • 36.Alvarez-Larran A, Toll T, Rives S, Estella J. Assessment of neutrophil activation in whole blood by flow cytometry. Clinical and laboratory haematology. 2005;27:41–46. doi: 10.1111/j.1365-2257.2004.00661.x. [DOI] [PubMed] [Google Scholar]
  • 37.Delano MJ, Thayer T, Gabrilovich S, Kelly-Scumpia KM, Winfield RD, Scumpia PO, Cuenca AG, Warner E, Wallet SM, Wallet MA, O&apos;Malley KA, Ramphal R, Clare-Salzer M, Efron PA, Mathews CE, Moldawer LL. Sepsis induces early alterations in innate immunity that impact mortality to secondary infection. The Journal of Immunology. 2011;186:195–202. doi: 10.4049/jimmunol.1002104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Brunkhorst BA, Lazzari KG, Strohmeier G, Weil G, Simons ER. Calcium changes in immune complex-stimulated human neutrophils. Simultaneous measurement of receptor occupancy and activation reveals full population stimulus binding but subpopulation activation. The Journal of biological chemistry. 1991;266:13035–13043. [PubMed] [Google Scholar]
  • 39.Nathan C, Shiloh MU. Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proceedings of the National Academy of Sciences of the United States of America. 2000;97:8841–8848. doi: 10.1073/pnas.97.16.8841. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Nordenfelt P, Tapper H. Phagosome dynamics during phagocytosis by neutrophils. Journal of leukocyte biology. 2011;90:271–284. doi: 10.1189/jlb.0810457. [DOI] [PubMed] [Google Scholar]
  • 41.Dale DC, Boxer L, Liles WC. The phagocytes: neutrophils and monocytes. Blood. 2008;112:935–945. doi: 10.1182/blood-2007-12-077917. [DOI] [PubMed] [Google Scholar]
  • 42.Beertsen W, Willenborg M, Everts V, Zirogianni A, Podschun R, Schroder B, Eskelinen EL, Saftig P. Impaired phagosomal maturation in neutrophils leads to periodontitis in lysosomal-associated membrane protein-2 knockout mice. Journal of Immunology. 2008;180:475–482. doi: 10.4049/jimmunol.180.1.475. [DOI] [PubMed] [Google Scholar]
  • 43.Craciun FL, Iskander KN, Chiswick EL, Stepien DM, Henderson JM, Remick DG. Early murine polymicrobial sepsis predominantly causes renal injury. Shock (Augusta, Ga) 2014;41:97–103. doi: 10.1097/SHK.0000000000000073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Remick DG, Bolgos G, Copeland S, Siddiqui J. Role of interleukin-6 in mortality from and physiologic response to sepsis. Infect Immun. 2005;73:2751–2757. doi: 10.1128/IAI.73.5.2751-2757.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Danikas DD, Karakantza M, Theodorou GL, Sakellaropoulos GC, Gogos CA. Prognostic value of phagocytic activity of neutrophils and monocytes in sepsis. Correlation to CD64 and CD14 antigen expression. Clinical and experimental immunology. 2008;154:87–97. doi: 10.1111/j.1365-2249.2008.03737.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Iskander KN, Craciun FL, Stepien DM, Duffy ER, Kim J, Moitra R, Vaickus LJ, Osuchowski MF, Remick DG. Cecal ligation and puncture-induced murine sepsis does not cause lung injury. Critical care medicine. 2013;41:159–170. doi: 10.1097/CCM.0b013e3182676322. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Doerschug KC, Powers LS, Monick MM, Thorne PS, Hunninghake GW. Antibiotics delay but do not prevent bacteremia and lung injury in murine sepsis. Critical care medicine. 2004;32:489–494. doi: 10.1097/01.CCM.0000109450.66450.23. [DOI] [PubMed] [Google Scholar]
  • 48.Dunay IR, Damatta RA, Fux B, Presti R, Greco S, Colonna M, Sibley LD. Gr1(+) inflammatory monocytes are required for mucosal resistance to the pathogen Toxoplasma gondii. Immunity. 2008;29:306–317. doi: 10.1016/j.immuni.2008.05.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Belaaouaj A, McCarthy R, Baumann M, Gao Z, Ley TJ, Abraham SN, Shapiro SD. Mice lacking neutrophil elastase reveal impaired host defense against gram negative bacterial sepsis. Nature medicine. 1998;4:615–618. doi: 10.1038/nm0598-615. [DOI] [PubMed] [Google Scholar]
  • 50.Alves-Filho JC, Ocirc Nego FS, Souto FO, Freitas A, Verri WA, Auxiliadora-Martins M, Basile-Filho A, Mckenzie AN, Xu D, Cunha FQ, Liew FY. Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection. Nature medicine. 2103;16:708–712. doi: 10.1038/nm.2156. [DOI] [PubMed] [Google Scholar]
  • 51.Delano MJ, Kelly-Scumpia KM, Thayer TC, Winfield RD, Scumpia PO, Cuenca AG, Harrington PB, O&apos;Malley KA, Warner E, Gabrilovich S, Mathews CE, Laface D, Heyworth PG, Ramphal R, Strieter RM, Moldawer LL, Efron PA. Neutrophil mobilization from the bone marrow during polymicrobial sepsis is dependent on CXCL12 signaling. The Journal of Immunology. 2011;187:911–918. doi: 10.4049/jimmunol.1100588. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Rauch PJ, Chudnovskiy A, Robbins CS, Weber GF, Etzrodt M, Hilgendorf I, Tiglao E, Figueiredo JL, Iwamoto Y, Theurl I, Gorbatov R, Waring MT, Chicoine AT, Mouded M, Pittet MJ, Nahrendorf M, Weissleder R, Swirski FK. Innate Response Activator B Cells Protect Against Microbial Sepsis. Science (New York, NY) 2012;335:597–601. doi: 10.1126/science.1215173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Inoue S, Unsinger J, Davis CG, Muenzer JT, Ferguson TA, Chang K, Osborne DF, Clark AT, Coopersmith CM, McDunn JE, Hotchkiss RS. IL-15 prevents apoptosis, reverses innate and adaptive immune dysfunction, and improves survival in sepsis. The Journal of Immunology. 2010;184:1401–1409. doi: 10.4049/jimmunol.0902307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Unsinger J, McGlynn M, Kasten KR, Hoekzema AS, Watanabe E, Muenzer JT, McDonough JS, Tschoep J, Ferguson TA, McDunn JE, Morre M, Hildeman DA, Caldwell CC, Hotchkiss RS. IL-7 promotes T cell viability, trafficking, and functionality and improves survival in sepsis. Journal of immunology (Baltimore, Md : 1950) 2010;184:3768–3779. doi: 10.4049/jimmunol.0903151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Saeed S, Quintin J, Kerstens HH, Rao NA, Aghajanirefah A, Matarese F, Cheng SC, Ratter J, Berentsen K, van der Ent MA, Sharifi N, Janssen-Megens EM, Ter Huurne M, Mandoli A, van Schaik T, Ng A, Burden F, Downes K, Frontini M, Kumar V, Giamarellos-Bourboulis EJ, Ouwehand WH, van der Meer JW, Joosten LA, Wijmenga C, Martens JH, Xavier RJ, Logie C, Netea MG, Stunnenberg HG. Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity. Science. 2014;345:1251086. doi: 10.1126/science.1251086. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Biswas SK, Lopez-Collazo E. Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends in immunology. 2009;30:475–487. doi: 10.1016/j.it.2009.07.009. [DOI] [PubMed] [Google Scholar]
  • 57.Brudecki L, Ferguson DA, McCall CE, El Gazzar M. Myeloid-derived suppressor cells evolve during sepsis and can enhance or attenuate the systemic inflammatory response. Infect Immun. 2012;80:2026–2034. doi: 10.1128/IAI.00239-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Derive M, Bouazza Y, Alauzet C, Gibot S. Myeloid-derived suppressor cells control microbial sepsis. Intensive care medicine. 2012;38:1040–1049. doi: 10.1007/s00134-012-2574-4. [DOI] [PubMed] [Google Scholar]
  • 59.Hotchkiss RS, Strasser A, McDunn JE, Swanson PE. Cell death. The New England journal of medicine. 2009;361:1570–1583. doi: 10.1056/NEJMra0901217. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Zhang Y, Zhou Y, Lou J, Li J, Bo L, Zhu K, Wan X, Deng X, Cai Z. PD-L1 blockade improves survival in experimental sepsis by inhibiting lymphocyte apoptosis and reversing monocyte dysfunction. Crit Care. 2010;14:R220. doi: 10.1186/cc9354. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

1

RESOURCES